Department of Health and Nutrition Biotechnology, Asia University, Taichung, Taiwan.
Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, No. 91, Hsueh-Shih R., Taichung 40402, Taiwan.
Oxid Med Cell Longev. 2020 Feb 6;2020:7912763. doi: 10.1155/2020/7912763. eCollection 2020.
Acute kidney injury (AKI) is a common clinical problem, characterized by a sudden loss of renal function, a high risk of death, and the eventual development of renal fibrosis and renal failure. is a traditional Chinese medicine with the potential function of kidney protection. We analyze two sputum extracts, a water extract (WCC), and an ethanol extract (ECC), to assess the potential of treating AKI in an animal model of kidney injury induced by cisplatin. A nephrotoxic mouse model was first established by intraperitoneal injection of cisplatin. Subsequently, WCC and ECC were orally administered in these mice. The results show that WCC and ECC significantly alleviated cisplatin-induced AKI renal histological changes, serum creatinine (CRE) and blood urea nitrogen (BUN) production, and the levels of NO, TNF-, IL-1, and IL-6. The levels of malondialdehyde (MDA) and glutathione (GSH) were suppressed by administration of WCC and ECC. However, WCC treatment prevented these changes significantly better than ECC treatment. In addition, Western blot data showed that WCC attenuated the cisplatin-induced protein expression of cyclooxygenase-2 (COX-2) and inducible NO synthase (iNOS), as well as inhibiting nuclear factor-kappa B (NF-B) and mitogen-activated protein kinase (MAPK) activation in the kidney tissues. Furthermore, WCC greatly inhibited the expression of Toll-like receptor 4 (TLR4) and cisplatin-induced NF-B activation, as well as dramatically increasing the production of antioxidative enzymes (i.e., superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase, nuclear factor erythroid 2-related factor 2 (Nrf2), and heme oxygenase 1 (HO-1)), silent information regulator T1 (Sirt1), and p-AMP-activated protein kinase (AMPK) in the kidney tissues. In addition, we found that WCC increased the expression levels of the autophagy-related proteins LC3B and Beclin-1; proapoptotic proteins, including cleaved caspase-3 and cleaved poly (ADP-ribose) polymerase (PARP) 1; and organic anion transporters 1 (OAT1) and 3 (OAT3) in the kidney tissues. Finally, WCC, ECC, and two bioactive compounds-adenosine and N6-(2-hydroxyethyl) adenosine (HEA)-inhibited the production of nitrite oxide (NO) and intracellular reactive oxygen species (ROS) triggered by lipopolysaccharide- (LPS-) stimulated RAW264.7 macrophages . Collectively, WCC could provide a potential therapeutic candidate for the prevention of cisplatin-induced kidney injury through the inhibition of oxidative stress and inflammation.
急性肾损伤(AKI)是一种常见的临床问题,其特征为肾功能突然丧失,死亡风险高,最终发展为肾纤维化和肾衰竭。 是一种具有肾脏保护作用的中药。我们分析了两种痰提取物,水提取物(WCC)和乙醇提取物(ECC),以评估它们在顺铂诱导的肾损伤动物模型中治疗 AKI 的潜力。首先通过腹腔内注射顺铂建立肾毒性小鼠模型。随后,将 WCC 和 ECC 口服给予这些小鼠。结果表明,WCC 和 ECC 显著减轻了顺铂诱导的 AKI 肾组织学变化、血清肌酐(CRE)和血尿素氮(BUN)的产生以及 NO、TNF-、IL-1 和 IL-6 的水平。WCC 和 ECC 抑制丙二醛(MDA)和谷胱甘肽(GSH)的产生。然而,WCC 治疗对这些变化的预防作用明显优于 ECC 治疗。此外,Western blot 数据显示,WCC 减弱了顺铂诱导的环氧合酶-2(COX-2)和诱导型一氧化氮合酶(iNOS)的蛋白表达,抑制了核因子-κB(NF-κB)和丝裂原活化蛋白激酶(MAPK)在肾脏组织中的激活。此外,WCC 极大地抑制了 Toll 样受体 4(TLR4)和顺铂诱导的 NF-κB 激活的表达,并显著增加了抗氧化酶(即超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GPx)、过氧化氢酶、核因子红细胞 2 相关因子 2(Nrf2)和血红素加氧酶 1(HO-1))、沉默信息调节因子 T1(Sirt1)和 p-AMP 激活蛋白激酶(AMPK)在肾脏组织中的产生。此外,我们发现 WCC 增加了自噬相关蛋白 LC3B 和 Beclin-1 的表达水平;促凋亡蛋白,包括 cleaved caspase-3 和 cleaved poly(ADP-ribose)polymerase 1(PARP1);以及有机阴离子转运蛋白 1(OAT1)和 3(OAT3)在肾脏组织中的表达水平。最后,WCC、ECC 和两种生物活性化合物-腺苷和 N6-(2-羟乙基)腺苷(HEA)-抑制了脂多糖(LPS)刺激的 RAW264.7 巨噬细胞中一氧化氮(NO)和细胞内活性氧(ROS)的产生。总之,WCC 通过抑制氧化应激和炎症,可能为预防顺铂诱导的肾损伤提供一种潜在的治疗候选药物。